Environmental factors influencing the risk of ANCA-associated vasculitis

Environmental factors influencing the risk of ANCA-associated vasculitis

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a group of diseases characterized by inflammation and destruction of small and medium-sized blood vessels. Clinical disease phenotypes include microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinop...

Full description

Bibliographic Details
Main Authors:	Wen-Man Zhao, Zhi-Juan Wang, Rui Shi, Yu-Yu Zhu, Sen Zhang, Rui-Feng Wang, De-Guang Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Immunology
Subjects:	AAV (ANCA-associated vasculitis) ANCA air pollution environmental risks etiology vasculitis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.991256/full

Similar Items

The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies
by: Agata Walulik, et al.
Published: (2023-12-01)

Renal thrombotic microangiopathy in an ANCA-associated vasculitis
by: Ana Teresa Domingos, et al.
Published: (2019-10-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

ANCA-associated vasculitis in a 14 years-old patient: a clinical case
by: A. V. Burlutskaya, et al.
Published: (2020-10-01)

Newly diagnosed ANCA-associated vasculitis after COVID-19 infection: a case report
by: Kazuhiro Kitamoto, et al.
Published: (2023-08-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Complement Inhibition in ANCA-Associated Vasculitis
by: Vladimir Tesar, et al.
Published: (2022-07-01)

Hypophysitis Secondary to Small Vessel ANCA Vasculitis Treated With Rituximab
by: Nankee K. Kumar, AB, et al.
Published: (2024-03-01)

The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study
by: José Agapito Fonseca, et al.
Published: (2021-05-01)

B Lineage Cells in ANCA-Associated Vasculitis
by: Ana Merino-Vico, et al.
Published: (2021-12-01)

Systematic Histological Scoring Reveals More Prominent Interstitial Inflammation in Myeloperoxidase-ANCA Compared to Proteinase 3-ANCA Glomerulonephritis
by: Samy Hakroush, et al.
Published: (2021-03-01)

Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
by: Rocío Redondo-Rodriguez, et al.
Published: (2022-05-01)

Compromiso del sistema nervioso en vasculitis asociadas a ANCA
by: María Fernanda Quaglia
Published: (2018-06-01)

Blue toe syndrome as the initial manifestation of ANCA-associated vasculitis
by: Marinchev Liubomir, et al.
Published: (2013-10-01)

Cytomegalovirus infection is a risk factor for venous thromboembolism in ANCA-associated vasculitis
by: C. King, et al.
Published: (2022-08-01)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
by: D. Bele, et al.
Published: (2020-01-01)

Update of Management of ANCA-Associated Vasculitis
by: Hoi San Tang, et al.
Published: (2021-12-01)

Do Relapses Follow ANCA Rises? A Systematic Review and Meta-Analysis on the Value of Serial ANCA Level Evaluation
by: Aram Al-Soudi, et al.
Published: (2022-07-01)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
by: Yusuke Miyazaki, et al.
Published: (2020-06-01)

Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients
by: Peining Zhou, et al.
Published: (2022-01-01)

Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study
by: Adam D. Morris, et al.
Published: (2022-04-01)

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary
by: David Collister, et al.
Published: (2023-03-01)

ANCA vasculitis in a patient with Alport syndrome: a difficult diagnosis but a treatable disease!
by: Valentine Gillion, et al.
Published: (2017-03-01)

Comprehensive Analysis of Sex Differences at Disease Manifestation in ANCA-Associated Glomerulonephritis
by: Désirée Tampe, et al.
Published: (2021-09-01)

The frequency of ANCA-associated vasculitis in a national database of hospitalized patients in China
by: Jiannan Li, et al.
Published: (2018-10-01)

First reported case of ANCA-associated vasculitis induced by oxaliplatin, capecitabine, and trastuzumab
by: Bengang Huo, et al.
Published: (2023-12-01)

The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis
by: Christian Agosto‐Burgos, et al.
Published: (2022-01-01)

Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly
by: Roberta Fenoglio, et al.
Published: (2020-10-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

The HAVEN study—hydroxychloroquine in ANCA vasculitis evaluation—a multicentre, randomised, double-blind, placebo-controlled trial: study protocol and statistical analysis plan
by: Annastazia E. Learoyd, et al.
Published: (2023-04-01)

Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis
by: Gwen E. Thompson, et al.
Published: (2020-09-01)

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol
by: Mark E. McClure, et al.
Published: (2023-03-01)

Propylthiouracil-induced ANCA-negative cutaneous small vessel vasculitis
by: Aliaksandr Trusau, et al.
Published: (2018-01-01)

Coincidence of Systemic Lupus Erythematosus and ANCA-Associated Vasculitis: A Case Report with Perforation of Nasal Septum and Palate
by: Liu Y, et al.
Published: (2023-12-01)

A novel 4-dimensional live-cell imaging system to study leukocyte-endothelial dynamics in ANCA-associated vasculitis
by: Catriona A. Walls, et al.
Published: (2020-04-01)

Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
by: Elena Treppo, et al.
Published: (2021-08-01)

Caecal Ameboma, colorectal malignancy mimicker in young male with ANCA-associated vasculitis
by: Ali Al Lawati, et al.
Published: (2023-01-01)

The use of ECMO in pediatric granulomatosis with polyangiitis
by: Rachel Finkel, et al.
Published: (2022-05-01)

ANCA-associated vasculitis patients treated in Polish intensive care units – retrospective characteristics based on the POLVAS registry
by: Anna Włudarczyk, et al.
Published: (2020-10-01)